Monday, December 10, 2012
An Alabama woman is the first to file a suit from that state.
A 14th person has filed a lawsuit in Boston against Framingham-based New England Compounding Center, which is linked to a meningitis outbreak that has killed 36 people and sickened 541. The Boston Herald reported that a 31-year-old woman said she suffered temporary hearing loss and a painfully bloated face from an injection she received this summer at one of Alabama’s largest hospitals. The suit is the first from Alabama. The CDC is expected to release updated outbreak numbers today. The meningitis outbreak has led to the permanent closure of New England Compounding Center, and set inspectors' sights on Westborough-based Ameridose, which has the same owners. Ameridose has not been implicated in the outbreak. For full coverage of the NECC…
Tuesday, November 20, 2012
U.S. District Judge Dennis Saylor has ordered an expedited hearing to determine whether to freeze at least $461 million in assets belonging to New England Compounding Center, its owners and two related companies, according to court records.
Tuesday, November 20, 2012
A federal judge in Boston is expected to hear arguments today, Nov. 20, on whether to freeze nearly $500 million in assets, including luxury homes, related to New England Compounding Center, the Framingham-based specialty pharmacy linked to a deadly U.S. meningitis outbreak, reported Reuters. U.S. District Judge Dennis Saylor has ordered an expedited hearing to determine whether to freeze at least $461 million in assets belonging to New England Compounding Center, its owners and two related companies, according to court records. The fungal meningitis outbreak, linked to New England Compounding Center on Waverly Street in Framinghan, has killed 34 patients and infected almost 500 individuals in 19 states. The judge granted the request …
Wednesday, November 14, 2012
Appearing in front of the House Energy and Commerce Committee, the co-owner of NECC refused to answer question on the meningitis outbreak connected with his company.
Wrentham resident and co-founder of the New England Compound Center (NECC) Barry Cadden refused to speak during a congressional hearing today on the meningitis outbreak linked to his Framingham-based company. Being asked multiple questions by the House Energy and Commerce Committee, the NECC co-owner simply said said, "Under advice of counsel, I respectfully decline to answer under basis of my constitutional rights and privileges, including the Fifth Amendment." The House Energy and Commerce Committee convened the first hearing to examine the outbreak that has sickened about 440 people and caused 32 deaths across the country. Cadden said he would invoke his Fifth Amendment right to not answer questions to avoid self-incrimination. Since …
Monday, November 12, 2012
Ameridose responded to the findings in a statement.
Federal Food and Drug Administration inspectors saw insects and a bird while inspecting Ameridose, a Westborough facility that shares owners with the Framingham company connected to a national meningitis outbreak, WCVB reported today. The insects were seen "within 10 feet of a supposedly sterile area where drugs are manufactured," WCVB reported. "In another case, inspectors reported a bird flying into a room where drugs are stored." Ameridose responded to the findings in a statement. “We have received the FDA’s written observations included in their Form 483 that is based on a comprehensive 30-day review of our facilities and our processes, conducted by more than 20 inspectors representing both state and federal agencies," the statement …
Thursday, November 8, 2012
The Westborough-based company has been closed while cooperating with an FDA investigation.
Ameridose, the Westborough facility that shares owners with the Framingham company connected to a national meningitis outbreak, handed out hundreds of layoff notices today. The Boston Globe is reporting that the layoffs, which will start Friday, affect 650 workers at Ameridose and 140 at its affiliated marketing company, Medical Sales Management. Ameridose has been closed, and will remain closed until Nov. 19, to let the FDA inspect the facility. Ameridose has not been directly implicated in the meningitis outbreak. Its sister company, the Framingham-based New England Compounding Center, had its license revoked and is blamed for producing steroid injections that caused 31 deaths and 424 cases of fungal meningitis and joint infections. …
Thursday, October 11, 2012
The Framingham-based New England Compounding Center produced a steroid linked to a deadly meningitis outbreak, which has killed 12 people and infected 130 others across 10 states.
New England Compunding Center, which has been tied to the national memingitis outbreak, may have misled regulators and completed work beyond its state license, said Massachusetts Gov. Deval Patrick. The Framingham-based specialty pharmacy produced a steroid, that health officials believe killed 12 people, infected 130 others across 10 states, with a fungal meningitis. The governor told reporters Wednesday, "What they were supposed to be doing is filling specific prescriptions for specific patients, as I think any of us would understand a pharmacy to do. What they were doing instead is making big batches and selling them out of state as a manufacturer would and that is certainly outside of their state license." While the compounding …